Spok Holdings, Inc.
SPOK Healthcare Health Information Services
Spok Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $139.7 million, up 1.49% from fiscal 2024.
- Revenue
- −2.56%
- EPS
- +190.3%
- Free cash flow
- +61.6%
Quarter to September 2026, against a year earlier
Follow SPOK
Alert me
Spok Holdings, Inc. (SPOK) P/E ratio
As of 5 November 2026, Spok Holdings, Inc. (SPOK) trades at a P/E ratio of 12.9×. Over the past ten years it has ranged from 0.0× (December 2022) to 41.0× (November 2017); the current reading is higher than 60% of that period. That is below the Health Information Services industry median of 42.0× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 17.1× | (21.02%) |
| FY2024 | 21.7× | 11.12% |
| FY2023 | 19.5× | 155.20% |
| FY2022 | 7.6× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 31.3× | 597.17% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 11.6× | (32.05%) |
| Jun 2026 | 17.1× | (2.92%) |
| Mar 2026 | 17.6× | 2.63% |
| Dec 2025 | 17.1× | (19.56%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SY So-Young International Inc. Sponsored ADR compare | n/m |
| DH Definitive Healthcare Corp. compare | n/m |
| LFMD LifeMD, Inc. compare | n/m |
| HCAT Health Catalyst, Inc. compare | n/m |
| AMWL American Well Corporation compare | n/m |
| CARL Carlsmed, Inc. compare | n/m |
| CTEV Claritev Corporation compare | n/m |
| SPOK Spok Holdings, Inc. | 12.9× |
| OPRX OptimizeRx Corp. compare | 35.8× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)